<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071979/" ref="ordinalpos=2886&amp;ncbi_uid=3485216&amp;link_uid=PMC3071979" image-link="/pmc/articles/PMC3071979/figure/F2/" class="imagepopup">Figure 2. Activation of NFKB <span class="highlight" style="background-color:">signaling</span> in the skin of Sharpincpdm/Sharpincpdm mutant mice.  From: Inhibition of NFKB <span class="highlight" style="background-color:">signaling</span> retards eosinophilic dermatitis in SHARPIN-deficient mice. </a></div><br /><div class="p4l_captionBody">Pathway analysis of transcriptome data in skin using Ingenuity Pathway Analysis® software suggested activation of both classical and alterative NFKB pathways. Most of molecules in NFKB pathways were upregulated, such as p65/RelA and NFKB p52/RelB in the mutant group from the pooled expression data of 2-, 4-, 6-, 8-, and 10-week old mice.  upregulation;  downregulation; □ no significant change</div></div>